Industry News

Medtronic Launches NovaShield Injectable Nasal Packing and Stent for Functional Endoscopic Sinus Surgery (FESS)
Teva Announces FDA Approval of QNASL (Beclomethasone Dipropionate) Nasal Aerosol for Treatment of Children with Seasonal and Perennial Allergic Rhinitis
Texas A&M System sells off nearly half of drug manufacturer Kalon to Fujifilm
8 Western Pennsylvania hospitals penalized over infections
Global Factories Selects Thinfilm Printed Memory for Revolutionary New Blister Packaging System
Electronic Distribution of Prescribing Information for Human Prescription Drugs, Including Biological Products
Ireland : CELEBREX generic version introduced by Actavis
250 jobs to be cut as AstraZeneca closes plant
Strides Arcolab receives US FDA approval for Calcitriol Softgel Capsules; Product to be launched shortly
250 jobs to be cut as AstraZeneca closes plant
FDA Grants ARCA biopharma Orphan Drug Designation for rNAPc2 as a Potential Treatment for Ebola
Hantian Labs acquires leading nutriceutical company in Canada, Gravity Nutritionals
OPKO and Pfizer Enter into Global Agreement for OPKO's Long-Acting Human Growth Hormone (hGH-CTP)
Patterson Companies Acquires Holt Dental
Potential New Tool for Cervical Cancer Detection and Diagnosis
Salisbury bandage company stitches major deal with Walmart
Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics
Relypsa Announces FDA Acceptance of New Drug Application for Patiromer for Oral Suspension to Treat Hyperkalemia
QMED - FDA Upbeat about Medical Device Approval Times
Relypsa Announces FDA Acceptance of New Drug Application for Patiromer for Oral Suspension to Treat Hyperkalemia
OPKO and Pfizer Enter into Global Agreement for OPKO�s Long-Acting Human Growth Hormone (hGH-CTP)
Genentech Submits New Drug Application to FDA for Investigational Cobimetinib Used in Combination With Zelboraf (vemurafenib) in Advanced Melanoma
Medtronic Launches NovaShield Injectable Nasal Packing and Stent for Functional Endoscopic Sinus Surgery (FESS)
Genentech Submits New Drug Application to FDA for Investigational Cobimetinib Used in Combination With Zelboraf (vemurafenib) in Advanced Melanoma
FDA Warns of Serious Skin Reaction Associated with Antipsychotic Drug, Geodon, Parker Waichman LLP Comments